1. Market Research
  2. > Pharmaceutical Market Trends
  3. > IMS Pharmaceutical Pricing & Reimbursement Concise Guide: India

The Pharmaceutical Pricing & Reimbursement Concise Guides are established as the definitive reference and training text for P&R professionals around the world, drawing on the long-standing expertise of the IMS pricing and reimbursement specialists to provide industry players and decision makers with a thorough understanding of the rules and regulations governing P&R in international markets. This report covers key developments in P&R, market access, cost containment, trade margins and healthcare issues.

Table Of Contents

IMS Pharmaceutical Pricing and Reimbursement Concise Guide: India
INDIA 1
HEALTHCARE SYSTEM1
Facts and Figures 1
Market Indicators 2
Provision and Funding 4
PRICING6
Prescription Drugs 6
DPCO 20136
Non-DPCO Products 8
Patented Drugs10
Other Developments11
Generic Drugs 12
Hospital Drugs 12
Centralised Purchasing Agency 12
State-level Procurement 13
OTC Drugs 13
REIMBURSEMENT13
Admission to Reimbursement 13
Drug Reimbursement 13
Admission Procedures 14
Criteria for Inclusion15
State Schemes 16
Reimbursement Categories 16
Reimbursement Prices 16
Hospital Reimbursement 17
Formularies 17
Funding17
Changes in Reimbursement Status 17
NLEM18
NPPA Guidance for DPCO Product Withdrawals19
Changes in Reimbursement Prices 19
DPCO-controlled Products19
Non-scheduled Formulations 21
PHARMACOECONOMICS 22
Pharmacoeconomic Requirements 22
MoU with NICE22
PRICE BUILD UP24
Wholesalers 24
Margins 24
Background 25
Retail Pharmacies 26
Margins26
Background26
Generic Pharmacies 28
Dispensing Doctors 28
Sales Tax 29
COST CONTAINMENT29
Industry Paybacks 29
Promotional Costs 30
Patient Co-payments 31
Prescribing Controls 32
National Formulary 32
NLEM 32
Rational Usage and Monitoring32
E-prescribing 33
Generics 33
Generic Prescribing 34

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.